Dorian Petonnet
Research Subjects
Dorian Petonnet has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Anne Bouloc
Amgen Courbevoie France
1 shared publication- Anne-Geneviève Marcelin
Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, 75013 Paris, France
1 shared publication - Charline Ramahefasolo
AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 75013 Paris, France
1 shared publication Delphine Devulder
France Psoriasis Patients Association Paris France
1 shared publication- Emmanuel Mahe
Department of Dermatology Hôpital Victor Dupouy Argenteuil France
1 shared publication Gaelle Desamericq
Amgen Courbevoie France
1 shared publication
Latest Publications
- Open Access
- 18 November 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (1) , 188-193
Useful Instruments for Psoriasis Patients’ Follow‐Up in Teleconsultation Setting
Background: Teledermatology may be beneficial for psoriasis management and a working group of the International Psoriasis Council recently outlined the value of patient questionnaires in teledermatology. Objectives: Identify instruments that could optimise psoriasis evaluation when completed before a teleconsultation; assess patients’ and dermatologists’ opinions on the value of teleconsultations for managing psoriasis. Methods: This pilot, cross‐sectional study, conducted in France (November 2021 to February 2022), invited patients with psoriasis and dermatologists experienced in treating psoriasis to complete an electronic survey assessing (1) the value of teleconsultations, (2) the attributes of 12 specific instruments to be used in teleconsultation, and (3) the most important attributes of these instruments. The specific instruments assessed covered three domains: (1) Quality of life (QoL; Dermatology Life Quality Index [DLQI] and SKINDEX), (2) disease severity and involvement (Simplified Psoriasis Index [Sa‐SPI]; self‐evaluations of pruritus, pain and severity on a numeric rating scale [NRS]; self‐evaluations of involved body surface area [BSA]; skin photography), (3) rheumatology (Psoriatic Arthritis Uncluttered Screening Evaluation [PURE], Early ARthritis for Psoriatic patients [EARP], Psoriasis Epidemiology Screening Tool [PEST]). Results: From 100 patients responding, 75 were willing to be followed in a telemedicine setting. The instrument attributes most important to patients were helping overcome teleconsultation limitations and facilitating conversations. From 51 dermatologists responding, 42 were in favour of telemedicine. The instrument attributes most important to dermatologists were clinical relevance and helping overcome teleconsultation limitations. Patients and dermatologists ranked the tools similarly, with DLQI scoring higher than SKINDEX, and Sa‐SPI scoring higher than self‐evaluations of pruritus, pain and severity, self‐evaluations of involved BSA and skin photography. There was no preferred rheumatology questionnaire. Conclusions: Our data suggest DLQI, Sa‐SPI, and a rheumatology questionnaire could be useful to complete and transmit before a dermatology teleconsultation. These findings should be validated in a larger study with global participants.
- 18 November 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (1) , 188-193
Open AccessUseful Instruments for Psoriasis Patients’ Follow‐Up in Teleconsultation Setting
Background: Teledermatology may be beneficial for psoriasis management and a working group of the International Psoriasis Council recently outlined the value of patient questionnaires in teledermatology. Objectives: Identify instruments that could optimise psoriasis evaluation when completed before a teleconsultation; assess patients’ and dermatologists’ opinions on the value of teleconsultations for managing psoriasis. Methods: This pilot, cross‐sectional study, conducted in France (November 2021 to February 2022), invited patients with psoriasis and dermatologists experienced in treating psoriasis to complete an electronic survey assessing (1) the value of teleconsultations, (2) the attributes of 12 specific instruments to be used in teleconsultation, and (3) the most important attributes of these instruments. The specific instruments assessed covered three domains: (1) Quality of life (QoL; Dermatology Life Quality Index [DLQI] and SKINDEX), (2) disease severity and involvement (Simplified Psoriasis Index [Sa‐SPI]; self‐evaluations of pruritus, pain and severity on a numeric rating scale [NRS]; self‐evaluations of involved body surface area [BSA]; skin photography), (3) rheumatology (Psoriatic Arthritis Uncluttered Screening Evaluation [PURE], Early ARthritis for Psoriatic patients [EARP], Psoriasis Epidemiology Screening Tool [PEST]). Results: From 100 patients responding, 75 were willing to be followed in a telemedicine setting. The instrument attributes most important to patients were helping overcome teleconsultation limitations and facilitating conversations. From 51 dermatologists responding, 42 were in favour of telemedicine. The instrument attributes most important to dermatologists were clinical relevance and helping overcome teleconsultation limitations. Patients and dermatologists ranked the tools similarly, with DLQI scoring higher than SKINDEX, and Sa‐SPI scoring higher than self‐evaluations of pruritus, pain and severity, self‐evaluations of involved BSA and skin photography. There was no preferred rheumatology questionnaire. Conclusions: Our data suggest DLQI, Sa‐SPI, and a rheumatology questionnaire could be useful to complete and transmit before a dermatology teleconsultation. These findings should be validated in a larger study with global participants.
- Open Access
- 4 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (1) , 104
Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
SARS-CoV-2 viral antigen detection may be an interesting alternative to RT-PCR for the diagnosis of SARS-CoV-2 infection as a less laborious or expensive method but requires validation. This study aimed to compare the performance of the DiaSorin™ LiaisonXL automated quantitative antigen test (QAT) and the AAZ™ rapid antigen test (RAT) to the DiaSorin™ MDX RT-PCR assay. A total of 242 nasopharyngeal samples were tested at La Pitié-Salpêtrière University Hospital (Paris, France). Performances for the detection of variants of SARS-CoV-2 were further investigated. RATs were visually read for qualitative results and band intensity was determined. Overall sensitivity was 63.2% for QAT and 58.6% for RAT. For RT-PCR Ct value 25, sensitivity was 89.8% for both tests. Both tests showed comparable sensitivity for detection of variants. There was a strong relationship between antigen concentration and band positivity. On the same set of samples these tests share similar performances.
- 4 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (1) , 104
Open AccessComparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
SARS-CoV-2 viral antigen detection may be an interesting alternative to RT-PCR for the diagnosis of SARS-CoV-2 infection as a less laborious or expensive method but requires validation. This study aimed to compare the performance of the DiaSorin™ LiaisonXL automated quantitative antigen test (QAT) and the AAZ™ rapid antigen test (RAT) to the DiaSorin™ MDX RT-PCR assay. A total of 242 nasopharyngeal samples were tested at La Pitié-Salpêtrière University Hospital (Paris, France). Performances for the detection of variants of SARS-CoV-2 were further investigated. RATs were visually read for qualitative results and band intensity was determined. Overall sensitivity was 63.2% for QAT and 58.6% for RAT. For RT-PCR Ct value 25, sensitivity was 89.8% for both tests. Both tests showed comparable sensitivity for detection of variants. There was a strong relationship between antigen concentration and band positivity. On the same set of samples these tests share similar performances.